Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation
about
Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathwayModulation of mitogen-activated protein kinase-activated protein kinase 3 by hepatitis C virus core proteinThe Role of HBZ in HTLV-1-Induced OncogenesisSevere acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signalingLiver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transitionDegradation of AIMP1/p43 induced by hepatitis C virus E2 leads to upregulation of TGF-β signaling and increase in surface expression of gp96.Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.Immunomodulatory effects of transforming growth factor-β in the liver.Distinct expression profiles of TGF-beta1 signaling mediators in pathogenic SIVmac and non-pathogenic SIVagm infections.HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator.Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding to SMAD3Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer.Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5.Cytokine/chemokine patterns connect host and viral characteristics with clinics during chronic hepatitis C.dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection.The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-β1-induced growth inhibition by targeting Smad3 linker region.Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategiesKSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor.Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancerAn integrative approach for a network based meta-analysis of viral RNAi screensA Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival.TRAF6 is a novel NS3-interacting protein that inhibits classical swine fever virus replication.Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection.Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapy.Oncogenic Signaling Induced by HCV Infection
P2860
Q24307549-3694B69A-750F-4F00-AC47-613024206AD7Q24336062-597710DC-9B82-4B34-A8C3-B447CA994C8CQ26768630-54032F09-0AD6-4F3D-8F26-E5E1FDAC5293Q28259664-2F8DDC02-4C17-4A25-B839-D46BE5449BDCQ33405240-6764EE5B-4052-441F-8E21-0305AC4E9144Q33590116-23D66BD7-D65F-496B-8580-8B8F8CFD0A6BQ33904328-BAA8CD51-2DA6-4E9A-8EDE-9B2FA1985FF5Q34750481-BAEBD451-ACA5-43B1-A901-5AD203B0E270Q34944988-A5EEA3E9-8280-4440-A9EB-5EE0BF7251FBQ35172472-08B91A66-6E32-4231-A6A6-3568DC298DBBQ35185886-FCC34099-D123-4F07-90C3-3530BDF39249Q35576670-84DED7C0-C5E8-4B00-98D1-7565CF36B6EAQ35689725-6DDA4A36-83D7-4347-8540-441CE4110924Q36373301-F59C542E-6947-4C42-A6E4-2ED16D8A60F9Q36432681-793D4752-E2DF-4CE1-99DB-B7BA063CFCD7Q36561549-9398201C-E2E7-4E6A-AA9A-88BFBB34D430Q36561567-101166EE-B7FC-4D11-9F38-771F983B2B6FQ36591375-692F22FE-1A8A-436D-86B7-2A87BF75A594Q36812745-93353816-E5C3-47EB-979B-04A51F77AAF8Q38416102-BB1237CD-C9E8-4361-8EF3-CE1C41655B66Q39292510-2174332F-75EC-48B1-BD0E-D2C8F19EEFD7Q40045807-D91D10F2-81EB-4487-A4EC-063CD377B77CQ43041362-F653764E-4D27-42EE-8410-7D59CE97B17DQ55400314-27BF311A-6C79-4CDE-B01C-C4A56320BDC2Q57050806-8F4AEC5C-FD1F-4CCF-876C-7EF1798A5687
P2860
Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Hepatitis C viral proteins int ...... ted transcriptional activation
@ast
Hepatitis C viral proteins int ...... ted transcriptional activation
@en
Hepatitis C viral proteins int ...... ted transcriptional activation
@en-gb
Hepatitis C viral proteins int ...... ted transcriptional activation
@nl
type
label
Hepatitis C viral proteins int ...... ted transcriptional activation
@ast
Hepatitis C viral proteins int ...... ted transcriptional activation
@en
Hepatitis C viral proteins int ...... ted transcriptional activation
@en-gb
Hepatitis C viral proteins int ...... ted transcriptional activation
@nl
prefLabel
Hepatitis C viral proteins int ...... ted transcriptional activation
@ast
Hepatitis C viral proteins int ...... ted transcriptional activation
@en
Hepatitis C viral proteins int ...... ted transcriptional activation
@en-gb
Hepatitis C viral proteins int ...... ted transcriptional activation
@nl
P2093
P921
P356
P1433
P1476
Hepatitis C viral proteins int ...... ted transcriptional activation
@en
P2093
Meng-Hsiung Chang
Pei-Lin Cheng
Yan-Hwa Wu Lee
P2888
P304
P356
10.1038/SJ.ONC.1208066
P407
P577
2004-10-14T00:00:00Z
P5875
P6179
1020195544